Loading

logo

Journal of Physical Medicine and Rehabilitation

ISSN: 2690-0297

Editorial Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/rehabilitation.1.003

Introducing the New Journal in Physical Medicine and Rehabilitation

Arzu Razak Ozdincler1,*
  • 1Head, Department of Physiotherapy and Rehabilitation, Biruni University, Istanbul, Turkey
+ Affiliations - Affiliations

*Corresponding Author

Dr. Arzu Razak Ozdincler, aozdincler@biruni.edu.tr

Received Date: August 28, 2019

Accepted Date: September 04, 2019

Citation

Ozdincler AR. Introducing the New Journal in Physical Medicine and Rehabilitation. J Phys Med Rehab. 2019; 1(1):12.


Copyright
© 2019 Ozdincler AR. This is an open-access article distributed under the terms of the Creative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Editorial

It gives us great pleasure to introduce readers with our international peer-reviewed, open access journal. Journal of Physical Medicine and Rehabilitation is devoted to publish original research, reviews, and clinical reports on key areas of Physical Medicine and Rehabilitation and related fields. This journal aims to offer its readers important new information and ideas, intended to publish up-to-date information on various conditions.

The number of people in need of health services is increasing rapidly due to the aging population and the negativity of living conditions. This situation causes the health professionals to do more studies in this field. It is an important goal for these studies to reachout to relevant people and to gain more information.

Journal of Physical Medicine and Rehabilitation will highlight work from leading workers related to key advances in Physical Medicine and Rehabilitation. This peer-reviewed international journal serves as a best platform for researchers and clinicians to share their cutting-edge basic and clinical research on various therapy methods and rehabilitation techniques in providing comprehensive care and quality of life for individuals with physical impairments and disabilities. The journal publishes high quality research ideas and discoveries related to main subjects in Physical Medicine and Rehabilitation such as acute and chronic pain, pediatric rehabilitation, neurorehabilitation, speech and developmental disorders, spinal cord and brain injury stroke, multiple sclerosis, and cerebral palsy, arthritis and other joint problems, prosthetics and orthotics. And, we are also interested in development of new rehabilitative technologies. We welcome physiatrists and rehabilitation professionals to publish their latest findings in our journal. We hope our journal will offer a discussion platform to both clinicians and academicians.

Being aware of this need, our journal is guided by multicultural and multidisciplinary editorial board. The richness of our journal is that our board does not prejudice and gives importance only to the quality of the work done. We understand by speaking to authors, the need for reducing the publication time from submission to publication. Therefore, we have decided to provide fast-track peer-review (14-18 days), rapid publication (3 business days from acceptance) and enhanced global visibility of published articles through open access. We are focusing on quality outcomes of relevant research that will empower the field of Rehabilitation in many ways. Our expert editorial panel will evaluate the articles and give suggestions for all articles submitted to the journal.

Our journal has very good achievement in a very short time. I sincerely believe that it would be a preferred journal in the field soon. I invite health professionals to send us their work and follow-up.

Recommended Articles

The Nature of Radiation-induced Inherited Recessive Gene Mutations in Drosophila Melanogaster

The nature of gene mutations induced by ionizing radiation in germ cells and transmitted to offspring remains one of the most important problems in radiation genetics of higher eukaryotes. The data accumulated in this field were obtained by different authors under different experimental conditions which does not give a complete insight about the nature of radiation-induced inherited mutations at different genome levels (chromosome, gene, DNA). 

Karyotypic Profile of Chronic Myeloid Leukemia in Patients Diagnosed at Tertiary Level in Afghanistan

Balanced translocation resulting in fusion of the Abelson gene (ABL1) from chromosome 9q34 with the breakpoint cluster region (BCR) gene on chromosome 22q11.2 is the pathognomonic molecular driver of CML. The resulting BCRABL 1 fusion gene is both the diagnostic as well as therapeutic target of CML. The first agent with tyrosine kinase inhibitor activity that was licenced in 2000 for treatment of CML patients, was Imatinib, gradually followed by multiple agents with higher efficacy.

Escherichia coli Stress, Multi-cellularity, and the Generation of the Quorum Sensing Peptide EDF

Bacterial communication via quorum sensing (QS) molecules, as well as toxin-antitoxin (TA) gene modules located on bacterial chromosomes are well-studied mechanisms. Escherichia coli mazEF is a stress-induced TA system mediating cell death requiring a QS extracellular death factor (EDF), the pentapeptide NNWNN. MazF is an endoribonuclease specific for ACA sites. During adverse conditions, the activated MazF generates a stress induced translation machinery, composed of MazF-processed mRNAs and selective ribosomes that specifically translate these processed mRNAs.

Constitutively Active Death Receptor Induces Apoptosis in Mammalian Cells

Apoptosis is a physiological response in development and homeostasis of metazoans. Apoptosis is triggered during pathological events as a means to renew affected tissues and eliminate cancer cells. The immune system regulates the extrinsic pathway of apoptosis, where signals such as TNFα or displayed ligands on the surface of immune cells trigger signal cascades by death receptors present on targeted cells.

Commentary on NOBOX Mutations in Premature Ovarian Insufficiency

NOBOX is an ovarian specific transcription factor that plays an important role in follicular growth and survival. Nineteen NOBOX variants have been previously associated with premature ovarian insufficiency (POI). Disease severity in patients with heterozygous and homozygous mutations largely overlap however, hampering genotype-phenotype correlations. We recently reported the first case of biallelic truncating mutations (NM_001080413.3 (NOBOX):c.826C>T, p.(Arg276*) and NM_001080413.3(NOBOX):c.1421del, p.(Gly474Alafs*76)) of NOBOX in two Belgian sisters with POI.

Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More